Profile: Elixir Medical Corporation develops products that combine medical devices with pharmaceuticals to provide treatment solutions. Drug-eluting stent systems are designed to optimize localized drug delivery to provide a safe treatment for cardiovascular patients. Our coronary stent is manufactured from a cobalt chromium alloy, which is used in vascular implants. Cobalt chromium offers strength & improved visualization under fluoroscopy compared to stents made from stainless steel. Our coronary stent has 33 percent lower strut thickness than a stainless steel stent, without compromising radial strength & radiopacity. Our Novolimus™ is a mTOR inhibitor macro-cyclic lactone with anti-proliferative & anti-inflammatory properties developed for drug eluting stents.
FDA Registration Number: 3005092783
15 Products/Services (Click for related suppliers)
|
• Bioabsorbable Hernia Plug |
• Bioabsorbable synthetic spacers |
• Coronary Covered Stent (FDA Code: NIV) |
• Coronary Drug-Eluting Stent (FDA Code: NIQ) |
• Coronary Stainless Steel Stents |
• Coronary Stent (FDA Code: MAF) |
• Coronary Stent Graft System |
• Coronary Stent Systems |
• Drug Eluting Stent Systems |
• Fully Bioabsorbable Drug Eluting Stent Systems |
• Pharmaceutical Items |
• Pharmaceuticals |
• Small Vessel Coronary Stent Systems |
• Stainless Steel and Cobalt Chromium Molybdenum Compression Hip Screws |
• Stent Delivery Systems |